BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17989903)

  • 1. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
    Wikström I; Stenvall H; Wilander E
    Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of genital human papillomavirus detection in a US population.
    Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
    J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical human papillomavirus screening among older women.
    Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
    Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening.
    Wikström I; Stenvall H; Wilander E
    Acta Obstet Gynecol Scand; 2007; 86(6):720-5. PubMed ID: 17520406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age.
    Winer RL; Feng Q; Hughes JP; Yu M; Kiviat NB; O'Reilly S; Koutsky LA
    Sex Transm Dis; 2007 Jun; 34(6):371-7. PubMed ID: 17065848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-sampling versus physician-sampling for human papillomavirus testing.
    Agorastos T; Dinas K; Lloveras B; Font R; Kornegay JR; Bontis J; de Sanjose S
    Int J STD AIDS; 2005 Nov; 16(11):727-9. PubMed ID: 16303065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated human papillomavirus DNA findings among female university students.
    Auvinen E; Zilliacus R; Malm C; Karkkulainen T; Fingerroos R; Paavonen J
    Int J STD AIDS; 2007 Dec; 18(12):839-41. PubMed ID: 18073018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS; Singh U
    Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection (HPV) & screening strategies for cervical cancer.
    Sehgal A; Singh V
    Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device.
    Stenvall H; Wikström I; Wilander E
    Acta Derm Venereol; 2006; 86(5):465-7. PubMed ID: 16955203
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do we go on screening?
    Marsan C
    Pol J Pathol; 2005; 56(4):167-9. PubMed ID: 16477875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of self-collection of specimens for HPV DNA testing in an urban population.
    Anhang R; Nelson JA; Telerant R; Chiasson MA; Wright TC
    J Womens Health (Larchmt); 2005 Oct; 14(8):721-8. PubMed ID: 16232104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HPV test makes cytological examination more accurate. Cervical cancer can be discovered more efficiently].
    Andersson S; Hjerpe A; Johansson BC; Hagmar B
    Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2797-9. PubMed ID: 17958005
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV testing. Visible expectations and hidden realities.
    Federschneider JM; Crum CP
    Am J Clin Pathol; 2003 Oct; 120(4):483-4. PubMed ID: 14560559
    [No Abstract]   [Full Text] [Related]  

  • 20. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
    Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
    Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.